bromodeoxyuridine has been researched along with octopamine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abel, T; Chung, H; Jang, DJ; Kaang, BK; Kim, B; Kim, H; Kim, SH; Kim, WR; Kim, YS; Ko, HG; Lee, JS; Lee, MY; Lee, N; Son, H; Son, J; Sun, W; Zhuo, M | 1 |
1 other study(ies) available for bromodeoxyuridine and octopamine
| Article | Year |
|---|---|
Induction of neuronal vascular endothelial growth factor expression by cAMP in the dentate gyrus of the hippocampus is required for antidepressant-like behaviors.
Topics: Analysis of Variance; Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Brain-Derived Neurotrophic Factor; Bromodeoxyuridine; Cell Line, Transformed; Chromatin Immunoprecipitation; CREB-Binding Protein; Cyclic AMP; Dentate Gyrus; Depression; Disease Models, Animal; Electrophoretic Mobility Shift Assay; Exploratory Behavior; Feeding Behavior; Fluoxetine; Food Preferences; Gene Expression Regulation; Humans; Male; Maze Learning; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neurogenesis; Neurons; Octopamine; Receptors, Biogenic Amine; RNA, Small Interfering; Transfection; Vascular Endothelial Growth Factor A; Vasoconstrictor Agents | 2009 |